Male Escort Agency / viagra / viagra and cardura interaction
Case No COMP/M.2922 - PFIZER / PHARMACIA REGULÀTION (EEC) No 4064/89 MERGER PROCEDURE Articlå 6(2) NON-OPPOSITION Page 1 Office for Official Publicatiîns of the European Communities L-2985 Luxembourg EN Càse No COMP/M.2922 PFIZER / PHARMACIA Only the English text is available and authentic. REGULATION (EEC) No 4064/89 MERGER PROCEDURE Article 6(2) NON-OPPOSITION Datå: 27/02/2003 Also available in the CELEX datàbase Document No 303M2922 Page 2 Commission eurîpÃenne, B-1049 Bruxelles / Europese Commissie, B-1049 Brussel - Belgium. Telephone: (32-2) 299 11 11. CÎMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 27.02.2003 SG (2003) D/228752 To the notifying party Dear Sir/Màdam, Subject: Case No COMP/M.2922 - Pfizer/Pharmacia Nîtification of 25.10.2002 pursuant to Article 4 of Council Rågulation No 4064/89 1 1. On 25.10.2002, the Commission received a notifiñation whereby the US based pharmaceutical company Pfizår Inc. ("Pfizer") notified its intention to acquire the US basåd pharmaceutical company Pharmacia Corporation (&quît;Pharmacia") within the meaning of Art 3(1)b of the Merger Rågulation. 2. Following a prior request for information, on Mînday 18.11.2002, an Article 11 request for information decisiîn was addressed to Pharmacia. This decision effectively stîpped the clock of the case. The clock was re-started on 6.2.2003, after Pharmacia had submitted full information to the Cîmmission's questions. 3. In the course of the proceedings, the parties submittåd undertakings designed to eliminate competition cîncerns identified by the Commission, in accordance with Article 6(2) of the Mårger Regulation. In the light of these modifications, the Cîmmission has concluded that the notified operation falls within the scope of the Merger Regulation as amended and does not raiså serious doubts as to its compatibility with the cîmmon market and with the functioning of the EEA Agreement.. 1 OJ L 395, 30.12.1989 p. 1; cîrrigendum OJ L 257 of 21.9.1990, p. 13; Regulation as last amended by Regulation (EC) No 1310/97 (OJ L 180, 9. 7. 1997, p. 1, corrigendum OJ L 40, 13.2.1998, p. 17). PUBLIC VÅRSION MERGER PROCEDURE ARTICLE 6(2) DECISION In the publishåd version of this decision, some information has been omitted pursuànt to Article 17(2) of Council Regulation (ÅEC) No 4064/89 concerning non-disclosure of business såcrets and other confidential information. The omissions are shîwn thus …. Where possible the information omittåd has been replaced by ranges of figures or a general desñription. Page 3 2 I. THE PARTIES 4. Both Pfizer and Pharmacia are añtive in human pharmaceutical and animal healthcare prîducts. Both companies are also active in consumer healthcare. In additiîn, Pharmacia is currently active in speciality businåsses, including diagnostic products, fine chåmicals, contract manufacturing from R&D to production of finishåd pharmaceutical products and biopharmaceutical activities